Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Clin Cancer Res. 2019 Nov 21;26(5):1086–1093. doi: 10.1158/1078-0432.CCR-19-2853

Table 1:

Age-standardized characteristics of statin users and nonusers in the Health Professionals Follow-up Study, mid-way through follow-up in 2002

Statin use
Never/past Current
N 26,845 (76%) 8,642 (24%)
Mean age a, years (SD) 68.0 (9.2) 68.9 (8.4)
White race, % 95.9 96.0
Mean height, inches (SD) 70.3 (2.7) 70.0 (2.6)
Mean BMI, kg/m2 (SD) 26.1 (3.8) 26.8 (3.7)
Mean BMI at age 21, kg/m2 (SD) 23.0 (2.9) 23.1 (2.8)
Family history of prostate cancer, % 12.5 11.6
Mean physical activity, MET hours/week (SD) 27.8 (22.4) 26.0 (19.4)
Smoking status, %
 Never 39.0 38.3
 Former, quit >10 years 31.1 39.1
 Former, quit ≤10 years 8.4 9.0
 Current 5.1 3.3
 Missing 16.4 10.3
History of diabetes, % 8.3 14.4
History of hypertension, % 42.4 58.3
History of high cholesterol, % 43.5 92.6
Had PSA test b, %
 1994 35.8 47.6
 2000 72.6 87.8
 2004 67.4 86.3
Mean tomato sauce intake, servings/week (SD) 1.1 (0.9) 1.1 (0.8)
Mean coffee intake, cups/day (SD) 1.6 (1.4) 1.7 (1.3)
Mean calorie intake, kcal/day (SD) 2001 (538) 1929 (505)
Statin use duration, years (SD) 0.3 (1.3) 5.6 (3.5)
Current medication use, %
 Aspirin 33.4 65.5
 Beta-blockers 9.3 27.7
 Calcium channel blockers 4.8 11.8
 Diuretics 7.8 16.0
 Other anti-hypertensives 8.6 19.3

Abbreviations: BMI, body mass index; MET, metabolic equivalent tasks, PSA, prostate-specific antigen; SD, standard deviation

a

Age comparisons are not age-standardized

b

Reported having a PSA test in the 2 years before the questionnaire date indicated